The Expert Consensus on the Treatment and Prevention of Bladder Function Disorders Secondary to Benign Prostatic Hyperplasia in 2022

Society of Minimally Invasive Surgery, Institute for Andrology, Shanghai Association of Chinese Integrative Medicine

PDF(931 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(931 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (10) : 1631-1637. DOI: 10.11748/bjmy.issn.1006-1703.2022.10.003
Guidelines and Recommendation

The Expert Consensus on the Treatment and Prevention of Bladder Function Disorders Secondary to Benign Prostatic Hyperplasia in 2022

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(10): 1631-1637 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.10.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(931 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉